|
|
|
|
|
|
|
M T Wed Th F |
|
23 September, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
Tomorrow's a big day for Heidi Overton, who's set to testify in her confirmation hearing to lead the FDA. The nominee will face members of the Senate HELP Committee, chaired by Bill Cassidy (R-LA), a staunch defender of vaccines. Overton is expected to have to defend her push for the MMR vaccine to be split into three individual shots, part of a sweeping presidential executive order.
But Overton recently received a hefty bit of political cover. Former FDA commissioners Scott Gottlieb and Mark McClellan backed her in a new op-ed, calling her "the right pick in a difficult moment." |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
|
|
|
by Zachary Brennan
|
Members of the FDA's Molecular and Clinical Genetics Panel and FDA officials on Wednesday raised questions about Grail's next-generation sequencing test for the early detection... | |
|
|
|
|
|
|
by Ayisha Sharma
|
OXFORD, England— The world's first therapy designed to fix a patient's unique genetic mutation cost $1.65 million to make, a key facilitator of the project... | |
|
|
|
|
|
|
by Max Gelman
|
One of Roivant’s leading autoimmune pipeline candidates failed a Phase 2b study in a form of lupus, the company said Wednesday morning. The program, known... | |
|
|
|
|
|
| . |
 |
|
|
|
by Andrew Dunn
|
KNOXVILLE, TN— Stephanie Marquart met the delivery guy before he could reach her front door. She’d been obsessively refreshing the tracking page, tracing the... | |
|
|
|
|
|
|
by Elizabeth Cairns
|
Roche moves closer to entering an increasingly crowded kidney disease market where Novartis, Calliditas, Travere, Otsuka and Vera already have approved drugs. The Swiss pharma... | |
|
|
|
|
|
|
|
Worldwide made. Thanks for reading.
|
| | |
